SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-219590
Filing Date
2024-09-16
Accepted
2024-09-16 16:05:53
Documents
13
Period of Report
2024-09-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d896018d8k.htm   iXBRL 8-K 23810
  Complete submission text file 0001193125-24-219590.txt   141897

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nerv-20240914.xsd EX-101.SCH 2877
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20240914_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20240914_pre.xml EX-101.PRE 10830
16 EXTRACTED XBRL INSTANCE DOCUMENT d896018d8k_htm.xml XML 3545
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 241301076
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)